Vitamin D deficiency is especially prevalent in postmenopausal women, and recommendations from current guidelines are inconsistent regarding vitamin D use.
A new Endocrine Society guideline for treating vitamin D deficiency calls for screening of persons at high risk for deficiency, but does not endorse such testing for others.
Clinicians should recommend vitamin D supplementation as well as exercise or physical therapy in community-dwelling adults aged 65 years or older who are at increased risk for falls.
After determining vitamin D deficiency and prescribing an eight-week course of weekly ergocalciferol (vitamin D2), when is the best time to reassess with a blood test?
Are you Sure the Patient with Osteoporosis should take Vitamin D? Management and Treatment of the Disease My patient with osteoporosis has a 25-hydroxyvitamin D level of 20 ng/ml. Is that enough? For the population in general, a 25-hydroxyvitamin D level of 20 ng/ml was considered adequate by the Institute of Medicine. For your patient…
Should patients be kept on a vitamin D regimen year round?
An epidemic of vitamin D deficiency in the Northern Hemisphere has been ignored for years. An endocrinologist recommended ergocalciferol 50,000 units three times a week for four to five weeks. If retesting shows improvement, dosing can be decreased to 50,000 units once a week. Alternatively, patients can be given OTC vitamin D 1,000 IU twice…
Vitamin D and calcium supplements do not reduce the risk for the development of colorectal adenomas, according to a study published in the New England Journal of Medicine.
At a Glance Vitamin D insufficiency/deficiency is common. The National Health and Nutrition Examination Survey (2001-2006) reported that levels of 25-hydoxyvitamin D (25[OH]D) were less than 20 ng/mL in 32% of the population. Screening everyone for vitamin D insufficiency/deficiency is not currently recommended. Indications for screening include: rickets, osteomalacia, or osteoporosis chronic kidney disease hepatic…
Vitamin D did not improve bone and muscle outcomes in postmenopausal women.